Products 212142-18-2

CAS 212142-18-2 appears in our catalog under these names: Vatalanib succinate, Vatalanib succinate, Vatalanib Succinate, >98.0%(HPLC)(T), Vatalanib (succinate), Vatalanib succinate, 99%. Offered by: GLPBio, TargetMol, Biosynth, TCI, MedChemExpress. Available pack sizes: 10mg, 50mg, 25mg, 100mg, 250mg, 10 mg, 50 mg, 5 mg.

Structural formula: {0} (CAS {1})

Vatalanib succinate is a succinate salt obtained by combining vatalanib with one molar equivalent of succinic acid. It is a multi-targeted tyrosine kinase inhibitor for all isoforms of VEGFR, PDGFR and c-Kit. It has a role as an antineoplastic agent, an angiogenesis inhibitor, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and a vascular endothelial growth factor receptor antagonist. It contains a vatalanib.

Source: ChEBI

Identity
Molecular formulaC24H21ClN4O4
Molecular weight464.9 g/mol
IUPAC namebutanedioic acid;N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine
InChIKeyLLDWLPRYLVPDTG-UHFFFAOYSA-N
SMILESC1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.C(CC(=O)O)C(=O)O

Computed by PubChem (NCBI)